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http://www.ctajournal.com/content/4/1/35RESEARCH Open AccessBronchoalveolar lavage in infants with recurrent
lower respiratory symptoms
Kristiina Malmström1*, Maili Lehto2, Marja-Leena Majuri2, Timo Paavonen3, Seppo Sarna4, Anna S Pelkonen1,
L Pekka Malmberg1, Harry Lindahl5, Merja Kajosaari5, Sejal Saglani6, Harri Alenius2 and Mika J Mäkelä1Abstract
Background: Few data are available about the inflammatory cytokine profile of bronchoalveolar lavage (BAL) from
young children with frequent wheeze. The first aim was to investigate the BAL cellular and cytokine profiles in infants
with recurrent lower respiratory symptoms in whom bronchoscopy was indicated for clinical symptom evaluation. The
second aim was to relate the BAL results with the histological findings of the endobronchial carina biopsies.
Methods: Thirty-nine infants (median age 0.9 years) underwent lung function testing by whole-body plethysmography
prior to the bronchoscopy. The BAL differential cell counts and cytokine levels were quantified. These findings were
compared with the histological findings of the endobronchial carina biopsies.
Results: The differential cytology reflected mainly that described for healthy infants with lymphocyte counts at the
upper range level. A positive association between BAL CD8+ lymphocytes and neutrophils and endobronchial reticular
basement membrane was found. Detectable levels of pro-inflammatory cytokine proteins IL-1β, IL-17A, IL-18, IL-23,
and IL-33 were found, whereas levels of Th2-type cytokine proteins were low. Frequent wheeze was the only clinical
characteristic significantly related to detectable combined pro-inflammatory cytokine profile. Lung function did not
correlate with any cytokine.
Conclusions: A positive association between BAL CD8+ lymphocytes and neutrophils and endobronchial reticular
basement thickness was found. Detectable production of pro-inflammatory cytokines associated positively with
frequent wheeze.
Keywords: Bronchoalveolar lavage, Infant, Pro-inflammatory cytokines, Pulmonary function, WheezeIntroduction
Two characteristic pathological features of asthma, thicken-
ing of the reticular basement membrane and eosinophilic
airway inflammation, are absent in symptomatic infants
with reversible airflow obstruction [1] but already present
in preschool children with severe, recurrent wheeze [2].
Instead, a network of antigen presenting dendritic cells
and macrophages, bronchus associated lymphoid tissue
structures, and Foxp3+ regulatory T cells have been
detected in endobronchial biopsies already in these
symptomatic infants [3].
Bronchoalveolar lavage (BAL) is a standardized method
to obtain cells from the airway lumen [4]. Increased* Correspondence: kristiina.malmstrom@fimnet.fi
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article, unless otherwise stated.numbers of eosinophils and mast cells have been detected
in BAL from school-aged children with atopic asthma but
not from preschoolers with viral wheeze [5]. In another
study, increased numbers of neutrophils and epithelial
cells were detected in BAL samples from school-aged
asthmatics and from young preschool children with viral-
induced wheeze [6]. Recently, children (5–17 years) with
severe therapy-resistant asthma had significantly increased
BAL eosinophils compared control subjects [7] but no
increase in BAL fluid interleukin (IL)-4, IL-5, or IL-13
levels. Interestingly a subgroup of children with Th2
cytokines had significantly lower lung function than
those with undetectable BAL fluid Th2 cytokines. To
our knowledge, there is no data about the inflammatory
cytokine profile of BAL samples from children less than
two years of age with troublesome lower airway symptoms
and wheeze.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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to investigate the BAL cellular and cytokine profiles in
a group of infants with defined lung function [1] in
whom bronchoscopy was indicated for clinical symptom
evaluation. Secondly, the BAL findings were compared
with the histological findings of the endobronchial carina
biopsies.Methods
Subjects
The study was established in January 29, 2000 and ended
in June 18, 2003. The children were referred to a tertiary
center for investigation of recurrent lower respiratory
tract symptoms (including dyspnea, cough, and wheeze).
As a part of their clinical assessment they underwent
lung function testing by whole body plethysmography at
the mean age of 0.9 years followed by bronchoscopy, BAL
and bronchial biopsy to exclude structural airway abnor-
malities, such as subglottic stenosis, laryngo-, tracheo-, or
bronchomalacia, and other diagnosis, such as foreign
body inhalation or mucus plugging [1]. The patients were
excluded if they had used corticosteroids within 8 weeks
of their lung function visit. Atopy was defined by a posi-
tive skin prick test to food or aeroallergens described
earlier [1]. Frequent wheeze was defined as ≥3 separate
doctor confirmed wheezing episodes. Functional residual
capacity, specific airway conductance, and bronchodilator
responsiveness were measured (+ve if specific airway
conductance increased >30%) [1]. Abnormal baseline lung
function was considered when specific airway conductance
was lower than that of 5th percentile (Z-score < −1.65)
of the reference range [8]. The clinical diagnose was
based on history, lung function, bronchoscopy, and follow-
up at 3 years of age and the children were categorized
having “asthma”, “structural abnormality”, or “unspecified
diagnosis”.Bronchoscopy, BAL and endobronchial biopsy
It had been routine clinical practice at the Hospital for
Children and Adolescents and Skin and Allergy Hospital,
University of Helsinki, to evaluate infants with either
chronic or recurrent respiratory difficulties using rigid
bronchoscopy. A pediatric surgeon performed bronchos-
copy and endobronchial biopsy under general anesthesia,
with a size 3.5 Stortz rigid bronchoscope, having an
outer diameter of 5.7 mm. BAL was performed with
Pentax FI-10BS bronchofiberoscope with 3.5 mm outer
diameter. The fiberoscope was wedged into a segmental
bronchus of the right lower lobe and 4×5 ml aliquots of
sterile saline were instilled and suctioned back on ice.
Since the first suctions will include some bronchial
mucus and epithelium, two first and two last suctions
were combined resulting in two separate fractions whereasthe second fraction would represent best the alveolar
level.
The carina biopsies taken from the main carina were
processed and analyzed for the thickness of reticular
basement membrane by light microscopy and for sube-
pithelial inflammatory cell counts (eosinophils, neutro-
phils, mast cells, plasma cells, lymphomononuclear cells)
indentified by their ultrastructure using transmission
electron microscopy as described earlier [1].
Cytokine analysis of BAL samples
The volume of retrieved BAL fluid was measured, cells
were counted and cell suspension was cytocentrifuged
onto microscopic slides. Epithelial and red blood cells,
differential cell counts, and CD4/CD8-lymphocytes were
determined [4].
Extraction of cellular RNA from BAL cells, synthesis of
cDNA and quantitative Real Time-PCR were performed
for IL-10, IL-13, IL-17A, IL-18, IL-33, TGF-1β, TSLP
(thymic stromal derived lymphoprotein), Foxp3, ST2, and
IL-1RAcP [9]. The house-keeping gene, ribosomal 18S,
was used during RT-PCR for normalization. Cytokine
protein analysis from BAL supernatants for IL-1β, IL-4,
IL-9, IL-12p70, and INF-α2 were made with the Luminex
bead system (Bio-Plex 200 System) by labeled cytokine
capture antibody pairs (Bio-Rad Laboratories), whereas
other cytokines were measured with commercial ELISA
kits: IL-10, IL-17A, and IL-23 (eBioscience, Inc., San Diego,
CA, USA), IL-13 (Eli-pair, Diaclone, Besancor Cedex,
France), IL-18 (Bender MedSystems, Vienna, Austria),
IL-28, TGF-β1, and TSLP (R&D Systems, Minneapolis,
MN, USA), IL-33 (Apotech, Epalinges, Switzerland).
Statistical analysis
Mann–Whitney U-test was used for comparisons of BAL
findings between the infant groups. Associations between
clinical parameters and BAL findings were calculated with
Chi-Square and Fisher’s tests. Correlations between cellular
and cytokine findings were calculated with Spearman’s
correlation-test. Two-sided p-values <0.05 were considered
statistically significant. The Ethics Committee of Diseases
of Children and Adolescents at the Helsinki University
Central Hospital approved the study protocol and written
informed parental consents were obtained.
Results
BAL samples were obtained from 39 infants: 30 children
with abnormal lung function and 9 children with normal
lung function. Asthma was diagnosed in 34, structural
abnormalities in 2 and prolonged mucus or cough in 3
children. In addition, mild structural abnormalities were
detected in 3 children with asthma. Structural abnormal-
ities included 2 laryngo-,1 tracheo- and 1 bronchomalacia
Table 2 Bronchoalveolar cell profiles
BAL
fraction 1
BAL
fraction 2
N 39 34
Median of BAL fluid recovery volume (ml) 2.0 (0.3–5.4) 3.2 (0–6.8)
Median of BAL fluid recovery volume (%) 20 (3–54) 32 (0–68)
Median of total cell count (× 104/ml) 0.0 (0–29.7) 1.9 (0–15.5)
Median of differential BAL non-epithelial
cell count
Macrophages (%) 72.0 (0–95) 82.0 (0–98)
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of the children is presented in the Table 1.
BAL cell profiles and correlations with endobronchial cell
counts and RBM
BAL cellular findings are presented in Table 2. Macro-
phages were predominant cells in both fractions followed
by lymphocytes, whereas eosinophils were absent. The
number of lymphocytes in endobronchial biopsy corre-
lated positively with BAL fraction 1 CD8-lymphocytes
(r = 0.734, p = 0.007; Spearman) and negatively with ratio ofTable 1 Characteristics of infants at the time of lung
function test and findings of bronchial biopsy
N 39
Age, years, median (range) 0.88 (0.28–1.94)
Sex, male 25 (64%)
Parental asthma 26 (41%)
Parental smoking 9 (23%)
Symptoms
Age at first symptoms (y) 0.25 (0–1.33)
Duration (y) 0.58 (0.17–1.33)
Wheeze 23 (59%)
Frequent wheeze* 15 (38%)
Cough 26 (67%)
Mucus 23 (59%)
Dyspnea 5 (13%)
SPT+ 15 (38%)
SPT + &/or eczema 24 (62%)
Lung function
Abnormal 30 (77%)
Abnormal with + ve BDR 12 (40%)
sGaw, z-score −2.4 (−5.2–0.9)
FRC, z-score 0.37 (−1.5–1.9)
Bronchial biopsy findings
RBM, μm 3.8 (2.7–6–0)
Plasma cells/area 1.3 (0–13.8)
Neutrophils/area 0.07 (0–0.88)
Mast cells/area 0.39 (0–1.26)
Lymphocytes/area 1.7 (0–16.9)
Total cells/area 31.4 (16.9–138.9)
Dg at infancy
Asthma 34 (87%)
Structural abnormality 5 (13%)
Unspecified 3 (8%)
Lung function and bronchial biopsy findings are presented as medians (range).
*Frequent wheeze, ≥ 3 times.
SPT, skin prick test; BDR, bronchodilator response (sGaw >30%); sGaw, specific
airway conductance; FRC, functional residual capacity; RBM, reticular
basement membrane.
Lymphocytes (%) 6.0 (0–19) 13.0 (0–49)
Neutrophils (%) 5.0 (0–82) 2.0 (0–35)
Eosinophils (%) 0.0 (0–2) 0.0 (0–1)
Basophils (%) 0.0 (0–2) 0.0 (0–2)
CD4+ (%) 10 (0–50) 19.5 (0–65)
CD8+ (%) 18.0 (0–78) 39.0 (0–70)
CD4+/CD8+ 0.63 (0–2.14) 0.43 (0–2.17)
Median of epithelial cell count (%) 15.0 (0–100) 5.0 (0–80)
*The results are expressed as median (range).CD4/CD8-lymphocytes (r = −0.739, p = 0.037; Spearman).
The thickness of RBM correlated positively with the
BAL fraction 1 CD8+ lymphocyte % (r = 0.488, p = 0.047;
Spearman), and with BAL fraction 2 lymphocyte % (r =
0.473, p = 0.017; Spearman) and neutrophil % (r = 0.499,
p = 0.011; Spearman). There were no differences in BAL
cellular findings between the children with and without
infant asthma, neither between the children with normal
and abnormal lung function.
BAL cytokines
Analyses of cytokine proteins in BAL fluid and of cyto-
kine mRNAs in BAL cells were available from 32 and 36
patients. Detectable levels of pro-inflammatory cytokine
proteins IL-1β, IL-17A, IL-18, IL-23, and IL-33 were found
whereas levels of Th2-type cytokine proteins, such as IL-4,
IL-9, IL-13, and TSLP, were undetectable (Figure 1A).
Besides, 13 children had low BAL cytokines for all mea-
sured cytokines. At the mRNA level, the expression of
many cytokines were observed i.e. pro-inflammatory
cytokine IL-18, TGF-β1, IL-13 and TSLP. In addition,
the mRNA expression of regulatory T-cell marker
Foxp3+ as well as RacP, co-receptor IL-1 for IL-1β, IL-33
and IL-36 were discovered (Figure 1B). Again, there were
no differences in cytokine proteins in BAL fluid or cyto-
kine mRNA expression between the children with and
without infant asthma, neither between the children with
normal and abnormal lung function.
BAL cytokine correlations
The group of 19/32 (59%) patients with detectable levels
of pro-inflammatory cytokine protein production (IL-1β,
Figure 1 Bronchoalevolar lavage fluid cytokine proteins (A) and mRNA expression of bronchoaleveolar lavage cell cytokines (B). White
circles, children with normal lung function. Black circles, children with abnormal lung function. Lines are means of all data. RU, relative units.
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Figure 2 Pro-inflammatory cytokine protein levels of
bronchoalveolar lavage supernatants in frequent wheezers,
wheezers and non-wheezers. Frequent wheeze and wheeze
were significantly (p = 0.004 and p = 0.029, Fisher) related to the
detectable combined pro-inflammatory cytokine profile (IL-1β, IL-17,
IL-18, IL-23, and IL-33). Lines express means of data.
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characteristics. Frequent wheeze and wheeze were the
only clinical characteristics significantly related to this
detectable combined pro-inflammatory cytokine profile
(p = 0.004 and p = 0.029, Fisher) (Figure 2). Neither
lung function, atopy, duration of symptoms, age at the
beginning of the symptoms, endobronchial cell counts,
nor thickness of reticular basement membrane showed any
associations with the pro-inflammatory cytokines. Detect-
able level of IL-1β was positively correlated with BAL
fraction 1 lymphocytes and CD4+ lymphocytes (r = 0.526,
p = 0.014; r = 0.537, p = 0.039; Spearman). In addition,
detectable level of IL-17A was positively correlated
with BAL fraction 2 macrophages (r = 0.438, p = 0.032;
Spearman).
Discussion
The present study characterized BAL cell counts and
cytokine profiles in a group of infants with recurrent
lower respiratory tract symptoms of whom 87% were
diagnosed for asthma. For ethical reasons a healthy
control group could not be included. Macrophages
were predominant cells followed by lymphocytes. In
addition, detectable levels of pro-inflammatory cytokine
proteins IL-1β, IL-17A, IL-18, IL-23, and IL-33 were
found.
The role of bronchial epithelial eosinophilia has been
controversial in childhood asthma [1,2,10,11]. Bronchial
epithelial eosinophilia was not detected in the bronchial
biopsies from the same corticosteroid-naive infants than
in the present study [1]. The absence of BAL fluid eo-
sinophilia in the present study supports the observations
[6] that other cells than eosinophils are important in
symptomatic children at the early age.
We found a positive association between the percent-
age of BAL fraction 1 CD8+ lymphocytes and thickness
of reticular basement membrane and the number of
lymphocytes in the endobronchial biopsy. In addition, a
positive association was found between the percentages
of BAL fraction 2 lymphocytes and neutrophils and the
thickness of reticular basement membrane. These findings
may have important implications since CD8+ lymphocytes
potentiate development of airway hyperresponsiveness
in experimental models and may amplify inappropriate
immune responses seen in developing asthma [12]. Van
Rensen and co-workers investigated the prognostic sig-
nificance of bronchial CD8+ lymphocytes, eosinophils,
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subsequent decline in lung function in adult asthmatics
after 7.5 years of follow-up [13]. They found an annual
decline of lung function that correlated with bronchial
CD8+ lymphocytes but not with eosinophils or reticular
basement membrane thickness. They speculated that
since CD8+ lymphocytes can induce potential conditions
that are required for changes in airway structure, this may
eventually lead to changes in airway structures.
Activation of pro-inflammatory cytokine production is
a requirement for the adaptive immune system function.
In this study, detectable levels of pro-inflammatory cyto-
kines were found in BAL samples especially among
infants with frequent wheeze regardless of current lung
function. We did not find Th2 dominance (IL-4, IL-13,
IL-9) or differences in the regulatory cytokines (i.e. IL-10,
TGF-β1). In accordance to our findings, a significant
T-cell driven airway inflammation was absent in mild/
non-atopic 2–12 year old asymptomatic children with
episodic wheeze according to intracellular cytokine
IFN-γ, IL-2, IL-4, IL-5, and IL-10 analyses of BAL fluid
[14]. Absence of Th2 cytokines IL4, IL-5 and IL-13 was
also detected in school children (median age 12 years)
with severe treatment-resistant asthma regardless of bron-
chial eosinophilia [7]. Pro-inflammatory cytokine IL-18 is
constitutively expressed in a wide range of cells, including
macrophages, dendritic cells, epithelial cells, and endothe-
lial cells [15]. Thus, it is possible that IL-18 protein in
BAL fluids originates from different lung tissue cells for
instance from damaged airway epithelial cells as well as
from macrophages circulating in BAL fluids. Production
of pro-inflammatory cytokines is assumingly part of nor-
mal immunological maturation process during infancy. It
is likely that children with frequent wheeze suffer from
repeated viral infections, which may upgrade production
of pro-inflammatory cytokines.
The instilled saline volume varies in protocols but
3 ml/kg has been recommended [4]. A smaller instilled
volume in the present study, 20 ml/infant averaging
2 ml/kg, could explain low recovery volume and total
cell number. The differential cytology reflected mainly
that described for healthy infants in another studies
recognizing that normal value range is wide and over-
lapping [4,16]. Eosinophils were absent whereas other
inflammatory cells were found. Median lymphocyte
count 13% in fraction 2 was at the upper scale of that
described for very young healthy controls [4] and
wheezing infants [6].
We conclude that a positive association between per-
centage of BAL CD8+ lymphocytes and neutrophils and
the thickness of reticular basement membrane in the
endobronchial biopsy was found. Pro-inflammatory cyto-
kines were detected in BAL fluids of infants with recur-
rent respiratory symptoms regardless of current lungfunction. Frequent wheeze and wheeze were the only
characteristics significantly associated with detectable
levels of pro-inflammatory cytokines.
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